Projectes

IrsiCaixa compta amb un centenar de projectes de recerca nacionals i internacionals actius cada any, finançats tant per entitats públiques com privades.

Paraules clau

Grup de recerca

Investigador/a

Des del

Fins el

DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors

Estatus del projecte

Vigent

Inici/Fi

2017

/

2019

Investigador/a principal

Javier Martínez-Picado

Entitats participants

Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute.

Entitat finançadora

AstraZeneca
Non-invasive viral reservoir characterization in Lymph Nodes through Fine Needle Biopsies in patients with distinct HIV progression profiles

Estatus del projecte

Vigent

Inici/Fi

2017

/

2019

Investigador/a principal

Javier Martínez-Picado

Entitats participants

IrsiCaixa AIDS Research Institute

Entitat finançadora

Gilead Sciences
Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp

Estatus del projecte

Vigent

Inici/Fi

Investigador/a principal

Nuria Izquierdo Useros

Entitats participants

Irsicaixa, ICN2, UPV-CSIC

Entitat finançadora

MINECO
Allogeneic stem cell transplantation in HIV-1 infected individuals and 1st ITATI strategy

Estatus del projecte

Vigent

Inici/Fi

2018

/

2020

Investigador/a principal

Javier Martínez-Picado

Entitats participants

Foundation for AIDS Research amFAR (ARCHE program); ref 109858-64-RSRL
Treatment with immunological checkpoint inhibitors of HIV-infected subjects with cancer

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitat finançadora

Merck Sharp & Dohme de España, SA (MSD); ref IISP 57699
Characterisation of single molecule dynamics within HIV-1 reservoirs as a target for interference with virus persistence and immune evasion

Estatus del projecte

Vigent

Inici/Fi

2019

/

2020

Investigador/a principal

Javier Martínez-Picado

Jakub Chojnacki

Entitat finançadora

European Comission (H2020)
SIGTECH - New technologies mimicking virus-cell interaction to fight infectious diseases

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Nuria Izquierdo Useros

Entitat finançadora

Grifols
VIROCURE - Cutting edge strategies on HIV cure

Estatus del projecte

Vigent

Inici/Fi

2018

/

2023

Investigador/a principal

Javier Martínez-Picado

Entitat finançadora

Grifols
Exploratory, open-label, randomized clinical trial to assess the efficacy of first-line dual vs. triple antiretroviral therapy in HIV-1 reservoir and in peripheral compartments in HIV-infected patients

Estatus del projecte

Vigent

Inici/Fi

2019

/

2021

Investigador/a principal

Javier Martínez-Picado

Personal investigador extern

José Moltó

Entitats participants

AIDS Research Institute IrsiCaixa

Línia estratègica

Malalties infeccioses globals

Entitat finançadora

ViiV Healthcare
Glycoengineering nanovehicles to purge viral reservoirs

Estatus del projecte

Vigent

Inici/Fi

2018

/

2021

Investigador/a principal

Nuria Izquierdo Useros

Entitats participants

ICN2 and Biofisika-CISC

Entitat finançadora

Spanish Ministry of Economy and Competitiveness, ref. SAF2017-91767-EXP.